- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up - Abstract
September 4, 2013
Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy - Abstract
September 4, 2013
Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations - Abstract
September 4, 2013
Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer - Abstract
September 4, 2013
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer - Abstract
September 4, 2013
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors - Abstract
September 4, 2013
3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization - Abstract
September 3, 2013
Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection - Abstract
September 3, 2013
The phylogeny of permanent prostate brachytherapy - Abstract
September 3, 2013
Divorcing diagnosis from treatment: Contemporary management of low-risk prostate cancer - Abstract
September 3, 2013
External validation of the Cancer of the Prostate Risk Assessment-S score in Koreans undergoing radical prostatectomy - Abstract
September 3, 2013
Dose/volume-based evaluation of the accuracy of deformable image registration for the rectum and bladder - Abstract
September 3, 2013
Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement - Abstract
September 3, 2013
Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection - Abstract
September 2, 2013
Accurate patient selection and multimodal treatment offer the best therapeutic option in high-risk prostate cancer - Abstract
September 2, 2013
Current, new and novel therapy for castration-resistant prostate cancer - Abstract
September 2, 2013